Search results
Early intensified treatment cuts type 2 diabetes burden by USD 23 million in Korea
Medical Xpress· 15 hours agoA recent study by WifOR Institute highlights the societal benefits of early intensified treatment for Type 2 diabetes patients in Korea. Over a 10-year ...
Losing Muscle with GLP-1 RAs? There May be a Drug for That
Medscape· 1 day agoMedications in development would preserve muscle mass and augment fat loss when used in combination...
What's the Goal in Treating Type 2 Diabetes?
Medscape· 2 days agoAnne Peters discusses the differences in the newly published American College of Physicians and the American Diabetes Association guidelines for treating...
The One Thing You Should Never, Ever Do If You Have Prediabetes, According to an Endocrinologist
Parade· 7 days agoA doctor who treats diabetes gives tips on how to reverse this dangerous health condition. More than...
Does Daytime Hypoglycemia Contribute to Impaired Awareness?
Medscape· 4 days agoIn older adults with T1D, less daytime hypoglycemia was the biggest predictor of improvements in IAH...
Food Insecurity Quadruples Severe Hypoglycemia Risk in T2D
Medscape· 4 days agoBoth financial and physical food insecurity increased the risk, but standard questions didn't...
Epigenetic Markers May Predict Kidney Failure Risk in T1D
Medscape· 3 days agoMedscape Medical NewsEpigenetic Markers May Predict Kidney Failure Risk in T1DMarilynn Larkin May...
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss...
Digital Journal· 2 days agoTirzepatide is an FDA-approved medicine used to treat type 2 diabetes mellitus and may be used off-label for the treatment of obesity ...
Acrochordons may be marker for metabolic disease in children
Medical Xpress· 3 days agoIn pediatric patients, acrochordons may be a marker for metabolic disease, according to a study...
Structure Therapeutics (NASDAQ:GPCR) Shares Up 3.4%
ETF DAILY NEWS· 24 hours agoStructure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) shares rose 3.4% during mid-day trading on Wednesday . The company traded as high as $38.75 and last traded at $37.04. Approximately ...
